K2 Principal Fund, L.P. Ironwood Pharmaceuticals Inc Transaction History
K2 Principal Fund, L.P.
- $307 Million
- Q4 2024
A detailed history of K2 Principal Fund, L.P. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 25,000 shares of IRWD stock, worth $35,250. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$35,250% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
245Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$32.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$27.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$23.1 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$16.5 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$13.3 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $216M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...